DFON Biomedical Technology unveils new anti-ageing serum with MMpH+

DFON Biomedical Technology has unveiled a new serum with MMpH+ to help address skin ageing.

Called Enzyme Secret AP-I, the serum is claimed to offer comprehensive skin protection and regeneration from the effects of ageing, environmental factors and sun damage.

DFON’s Enzyme Secret AP-I is also said to balance matrix metalloproteinases (MMP) and key G enzymes, helping to restore the skin’s elasticity and radiance.

MMpH+ is a small molecule hyaluronic acid package material that has cleared several international tests on efficacy and safety. Originally used to encapsulate cancer drugs, MMpH+ was found to protect skin’s collagen and serve as a moisturiser.

According to DFON Biomedical founder and CEO Joshua Lai, other skincare products focus on stimulating collagen generation but neglect the importance of decelerating the loss of collagen.

Enzyme Secret AP-I was used by supermodel Jeanine Chin Hsi who tested her skin with an ultrasonic machine before using the product and saw considerable changes after two to three weeks of daily application.

DFON is the beauty products startup of ITRI. DFON was selected for the Paris&Co business acceleration programme. On a trial basis for six months in 2017, the firm sold more than 1,000 units of its products.